An interventional study of Child laughter video in Anxiety, Chemotherapy Effect and Laughter, sponsored by Selcuk University. Completed at 1 site in Turkey (Türkiye). Open to participants aged 32 Years to 81 Years. Per ClinicalTrials.gov, last updated 2025-07-04.
Sponsored by Selcuk University · Not applicable, Interventional, and Supportive care
This study was conducted to investigate the effect of video playback of children's laughter on anxiety, nausea, vomiting and fatigue levels of patients during chemotherapy
Nausea and vomiting, anxiety and fatigue due to chemotherapy can be prevented or reduced with effective nursing interventions and care. Laughter therapy is an intervention that has been used in the symptom management of individuals with cancer in recent years. Studies focusing on humor and laughter have generally been conducted among cancer patients. Humor and laughter have been shown to have both physiological, psychological and sociological benefits for patients in general. When the studies on laughter yoga are examined, it is seen that the results of laughter therapy applied to individuals are examined. It has also been reported in the literature that laughter has a contagious effect, often occurring in groups of people. There is no study in the literature on the effect of children's laughter on adults. This study will reveal the effectiveness of infant and child laughter in patients receiving chemotherapy. It is thought that this study will constitute an important data source for experimental studies to be conducted.
4,868 studies on the registry are indexed under Anxiety Disorders; 1,390 are open to participants now.
This study's enrollment of 36 is below the median of 80 across 4,174 interventional studies indexed under Anxiety Disorders.
Browse Anxiety Disorders studies →Selcuk University is the lead sponsor of 248 studies on the registry; 63 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Exclusion Criteria:
Patients in this group were made to watch the laughter video prepared by the researchers at the end of the 1st and 2nd hour after the start of chemotherapy.
Behavioral: Child laughter video
Participants in the control group were not subjected to any intervention other than routine practice during chemotherapy.
1 hour after the chemotherapy treatment was started, the video monitor was placed at a height where the patient could see comfortably while lying down and the video, which was checked and prepared beforehand, was turned on full screen. The appropriate volume was adjusted and the patient was allowed to watch the video for 10 minutes without any other intervention. The video was then stopped and the etagere was removed from in front of the patient. Chemotherapy was continued. At the 2nd hour of chemotherapy, the disinfected etagere and computer were placed in a position where the patient could see them comfortably and the 2nd video was started and the patient was allowed to watch the video for 10 minutes.
Patient information form
The form was designed by the researchers in two parts to assess personal characteristics and characteristics related to the disease and treatment.
Time frame: First measurement-10. minutes before the start of the patient's chemotherapy
Spielberger State Anxiety Scale
The scale measures the level of status anxiety of the patient with 20 questions.this form was applied in the pre-test and post-test phase
Time frame: First measurement- 5 minutes before the start of the patient's chemotherapy
FACIT Fatigue Scale
Developed by Singh in 2014, the scale was developed to evaluate the relationship between anemia and fatigue in cancer patients and to meet the increasing demand. This form was applied in the pre-test and post-test phase.
Time frame: First measurement- 1 minutes before the start of the patient's chemotherapy
Physiological Parameter Follow-up Form (Heart rate-min)
This form was created by researchers. When chemotherapy started and measured at the beginning of each hour.
Time frame: As soon as chemotherapy is started (Within first five minute)
Physiological Parameter Follow-up Form (Respiration rate- min)
This form was created by researchers. When chemotherapy started and measured at the beginning of each hour.
Time frame: As soon as chemotherapy is started (Within first five minute)
Physiological Parameter Follow-up Form (oxygen saturation -SpO2%)
This form was created by researchers. When chemotherapy started and measured at the beginning of each hour.
Time frame: As soon as chemotherapy is started (Within first five minute)
Physiological Parameter Follow-up Form (blood pressure- mmHg)
This form was created by researchers. When chemotherapy started and measured at the beginning of each hour.
Time frame: As soon as chemotherapy is started (Within first five minute)
Nausea Follow-up Form
With this form, the presence or absence of the patient's nause was questioned.Nausea was first measured at the start of chemotherapy
Time frame: As soon as chemotherapy is started (Within first five minute)
Vomiting Follow-up Form
With this form, the presence or absence of the patient's vomiting was questioned. Vomiting was first measured at the start of chemotherapy
Time frame: As soon as chemotherapy is started (Within first five minute)
Physiological Parameter Follow-up Form (Heart rate-min)
The measurement was made immediately after the first hour was full.
Time frame: Second measurement: 1. hour after starting chemotherapy
Physiological Parameter Follow-up Form (Respiration rate- min)
The measurement was made immediately after the first hour was full.
Time frame: Second measurement: 1. hour after starting chemotherapy
Physiological Parameter Follow-up Form (oxygen saturation -SpO2%)
The measurement was made immediately after the first hour was full.
Time frame: Second measurement: 1. hour after starting chemotherapy
Physiological Parameter Follow-up Form (blood pressure- mmHg)
The measurement was made immediately after the first hour was full.
Time frame: Second measurement: 1. hour after starting chemotherapy
Nausea Follow-up Form
The measurement was made immediately after the first hour was full.
Time frame: Second measurement: 1. hour after starting chemotherapy
Vomiting Follow-up Form
The measurement was made immediately after the first hour was full.
Time frame: Second measurement: 1. hour after starting chemotherapy
Physiological Parameter Follow-up Form (Heart rate-min)
The measurement was made immediately after the second hour was full.
Time frame: Third measurement: 2. hour after starting chemotherapy
Physiological Parameter Follow-up Form (Respiration rate- min)
The measurement was made immediately after the second hour was full.
Time frame: Third measurement: 2. hour after starting chemotherapy
Physiological Parameter Follow-up Form (oxygen saturation -SpO2%)
The measurement was made immediately after the second hour was full.
Time frame: Third measurement: 2. hour after starting chemotherapy
Physiological Parameter Follow-up Form (blood pressure- mmHg)
The measurement was made immediately after the second hour was full.
Time frame: Third measurement: 2. hour after starting chemotherapy
Nausea Follow-up Form
The measurement was made immediately after the second hour was full.
Time frame: Third measurement: 2. hour after starting chemotherapy
Vomiting Follow-up Form
The measurement was made immediately after the second hour was full.
Time frame: Third measurement: 2. hour after starting chemotherapy
Physiological Parameter Follow-up Form (Heart rate-min)
The measurement was made immediately after the third hour was full.
Time frame: Fourth measurement: 3. hour after starting chemotherapy
Physiological Parameter Follow-up Form (Respiration rate- min)
The measurement was made immediately after the third hour was full.
Time frame: Fourth measurement: 3. hour after starting chemotherapy
Physiological Parameter Follow-up Form (oxygen saturation -SpO2%)
The measurement was made immediately after the third hour was full.
Time frame: Fourth measurement: 3. hour after starting chemotherapy
Physiological Parameter Follow-up Form (blood pressure- mmHg)
The measurement was made immediately after the third hour was full.
Time frame: Fourth measurement: 3. hour after starting chemotherapy
Nausea Follow-up Form
The measurement was made immediately after the third hour was full.
Time frame: Fourth measurement: 3. hour after starting chemotherapy
Vomiting Follow-up Form
The measurement was made immediately after the third hour was full.
Time frame: Fourth measurement: 3. hour after starting chemotherapy
Physiological Parameter Follow-up Form (Heart rate-min)
The measurement was made immediately after the fourth hour was full.
Time frame: Fifth measurement: 4. hour after starting chemotherapy
Physiological Parameter Follow-up Form (Respiration rate- min)
The measurement was made immediately after the fourth hour was full.
Time frame: Fifth measurement: 4. hour after starting chemotherapy
Physiological Parameter Follow-up Form (oxygen saturation -SpO2%)
The measurement was made immediately after the fourth hour was full.
Time frame: Fifth measurement: 4. hour after starting chemotherapy
Physiological Parameter Follow-up Form (blood pressure- mmHg)
The measurement was made immediately after the fourth hour was full.
Time frame: Fifth measurement: 4. hour after starting chemotherapy
Nausea Follow-up Form
The measurement was made immediately after the fourth hour was full.
Time frame: Fifth measurement: 4. hour after starting chemotherapy
Vomiting Follow-up Form
The measurement was made immediately after the fourth hour was full.
Time frame: Fifth measurement: 4. hour after starting chemotherapy
This study is completed, as verified in Jun 2025. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Selcuk University